CLEVELAND, March 08, 2017 -- Chart Industries, Inc. (NASDAQ:GTLS), a leading diversified global manufacturer of highly engineered equipment for the industrial gas, energy, and biomedical industries, today reported that Michael L. Molinini was appointed to its Board of Directors on March 6, 2017.
Mr. Molinini served as Chief Executive Officer and President of Airgas, Inc. (“Airgas”) from August 2012 until May 23, 2016, and was Interim Chief Executive Officer from May 23, 2016 until June 30, 2016, when Airgas was acquired by Air Liquide. Mr. Molinini also served as a director of Airgas from May 2012 until May 2016. Before that time, Mr. Molinini served in various capacities at Airgas, including as Executive Vice President and Chief Operating Officer from January 2005 until August 2012, as well as positions at National Welders Supply Company and the Linde Division of Union Carbide Corporation.
“We are very excited to add Mike to the Chart Board and the Company will benefit from his substantial industry knowledge, executive experience and business acumen,” stated Sam Thomas, Chart’s Chairman and Chief Executive Officer.
Chart is a leading diversified global manufacturer of highly engineered equipment for the industrial gas, energy, and biomedical industries. The majority of Chart's products are used throughout the liquid gas supply chain for purification, liquefaction, distribution, storage and end-use applications, a large portion of which are energy-related. Chart has domestic operations located across the United States and an international presence in Asia, Australia, Europe and South America. For more information, visit: http://www.chartindustries.com.
Contact: Jim May Director - Corporate Development 216-626-2059 [email protected]


Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026 



